Leaflet REFLUDAN 50mg powder for solution for injection / infusion
Indicated for: heparin-induced thrombocytopenia; anticoagulation
Route of administration: injectable / infusion
Substance: lepirudin (anticoagulant)
ATC: B01AE02 (Blood and blood forming organs | Antithrombotic agents | Direct thrombin inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Lepirudin is an anticoagulant used for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). It is a direct thrombin inhibitor that prevents the formation of blood clots.
The medication is administered by intravenous or subcutaneous injection, and the dosage is adjusted based on body weight and the patient's coagulation levels. Treatment requires close monitoring to prevent the risk of excessive bleeding.
Side effects may include bleeding, injection site reactions, nausea, or headaches. In rare cases, severe allergic reactions may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow medical instructions. Pregnant or breastfeeding women should consult a specialist before use.
General data about REFLUDAN 50mg
- Substance: lepirudin
- Date of latest medicines list: 01-07-2013
- Product code: W55229001
- Concentration: 50mg
- Pharmaceutical form: powder for solution for injection / infusion
- Quantity: 1
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for lepirudin
- 20mg
- 50mg